Common Sense Health

ApoB: The Truth

19 min · 1. juni 2026
episode ApoB: The Truth cover

Description

The conversation delves into the rediscovery of ApoB as a significant cardiovascular marker and its suspiciously aligned timing with pharmaceutical profit motives. It explores the comparison between ApoB and LDLC, the rise of statins, the emergence of PCSK9 inhibitors, the controversy around ApoB, the context of metabolic dysfunction, and the pharmaceutical vs. metabolic approach to ApoB. It concludes with the distinction between treating a number and treating a disease. Takeaways * ApoB has become a significant cardiovascular marker * The timing of ApoB's rediscovery is suspiciously aligned with pharmaceutical profit motives Chapters * 00:00 Treating a Number vs. Treating a Disease

Comments

0

Be the first to comment

Sign up now and become a member of the Common Sense Health community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

299 episodes